Non-melanoma skin cancer

Lomas, 2012, A systematic review of worldwide incidence of non-melanoma skin cancer, Br J Dermatol, 166, 1069, 10.1111/j.1365-2133.2012.10830.x

Leigh, 2014, Progress in skin cancer: the U.K. experience, Br J Dermatol, 171, 443, 10.1111/bjd.13258

Ali, 2013, Systemic treatments for basal cell carcinoma (BCC): the advent of dermato-oncology in BCC, Br J Dermatol, 169, 53, 10.1111/bjd.12311

Cancer Research, 2015, Skin cancer statistics, London: CRUK

Pleasance, 2010, A comprehensive catalogue of somatic mutations from a human cancer genome, Nature, 463, 191, 10.1038/nature08658

Erb, 2008, Apoptosis and pathogenesis of melanoma and non-melanoma skin cancer, Adv Exp Med Biol, 624, 283, 10.1007/978-0-387-77574-6_22

Madan, 2010, Non-melanoma skin cancer, Lancet, 375, 673, 10.1016/S0140-6736(09)61196-X

Silverberg, 2013, HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer, J Natl Cancer Inst, 105, 350, 10.1093/jnci/djs529

Rubin, 2005, Basal cell carcinoma, N Engl J Med, 353, 2262, 10.1056/NEJMra044151

Wong, 2003, Basal cell carcinoma, BMJ, 327, 794, 10.1136/bmj.327.7418.794

Sexton, 1990, Histologic pattern analysis of basal cell carcinoma: study of a series of 1039 consecutive neoplasms, J Am Acad Dermatol, 23, 1118, 10.1016/0190-9622(90)70344-H

Telfer, 2008, Guidelines for the management of basal cell carcinoma, Br J Dermatol, 159, 35, 10.1111/j.1365-2133.2008.08666.x

Motley, 2002, Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma, Br J Dermatol, 146, 18, 10.1046/j.0007-0963.2001.04615.x

Rowe, 1989, Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up, J Dermatol Surg Oncol, 15, 315, 10.1111/j.1524-4725.1989.tb03166.x

Rowe, 1989, Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma, J Dermatol Surg Oncol, 15, 424, 10.1111/j.1524-4725.1989.tb03249.x

Braathen, 2007, Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus, J Am Acad Dermatol, 56, 125, 10.1016/j.jaad.2006.06.006

Lear, 2012, Oral hedgehog-pathway inhibitors for basal-cell carcinoma, N Engl J Med, 366, 2225, 10.1056/NEJMe1202170

Basset-Seguin, 2015, Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial, Lancet Oncol, 16, 729, 10.1016/S1470-2045(15)70198-1

Midgen, 2015, Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial, Lancet Oncol, 16, 716, 10.1016/S1470-2045(15)70100-2

Kim, 2014, Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma, J Clin Oncol, 32, 745, 10.1200/JCO.2013.49.9525